CHM chimeric therapeutics limited

Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-46

  1. 7,795 Posts.
    lightbulb Created with Sketch. 907
    Thanks for the advice.

    I’m happy with my understanding of biotech. There are many many many bio’s, with supposed high caliber management and boards who never succeed. And it’s not for the lack of knowledge.

    Back to that patient. They had a stem cell transplant in addition to CHM treatment. I’ll put their response in the bin and focus on the other patients responses. Underwhelming, imv.

    All the best.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.